ALIMENTARY PHARMACOLOGY & THERAPEUTICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2026-09-04 ms1000000059496168 来自上海

审稿速度:2.0 | 投稿命中率:25.0
经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。

42 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2024-07-01 ms1000001073912817 来自陕西省

状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择

1140 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2025-08-17 ms7000002977722169 来自北京

被拒了，总结了以下内容大家可酌情参考避雷：
官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。
总共邀请了2名编辑，协同 2 名及以上专家评审。
拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。
下次再接再厉吧。

123 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-11-08 JayNi

偏重的研究方向：肝脏疾病;肠道菌群
经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？

1181 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-01-25 ZZLLZZ

Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？

1263 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2025-01-18 ms8000002092849593 来自广东省

想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？

217 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-02-26 ms1000001073912817

这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？

1775 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2020-03-10 墨墨235

审稿速度:1.0
经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。

20 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2023-03-30 提奥多拉来自北京

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：诊断;消化;肝病
经验分享：投稿难度还是比较大的

1189 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2363813, encodeId=b207236381379, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：很好的杂志，文章质量很高。前几年和CGH同一档，现在影响因子没落了，但依旧口碑很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b2c8352435, createdName=ms1000000059496168, createdTime=Fri Sep 04 13:09:27 CST 2026, time=2026-09-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2212627, encodeId=dc02221262eba, content=状态在awaiting reviewer selection和awaiting reviewer assignment之间变换，估计投稿2周后拒稿，这杂志奇怪的很，不送审就赶紧拒稿，非要拖一段时间，不知道是什么意思。。。。。。不过肝病就那么几本杂志，实在是没什么选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1140, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Mon Jul 01 16:54:49 CST 2024, time=2024-07-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2277601, encodeId=000e22e76018f, content=被拒了，总结了以下内容大家可酌情参考避雷： 官网显示平均 11 天给出首次决策，实际我是快两个月才有结果（大家投稿前可多预留一些时间）。 总共邀请了2名编辑，协同 2 名及以上专家评审。 拒稿原因：研究主题不符期刊范畴；格式不规范，包括参考文献格式等，给了挺多反馈的，还是比较欣慰，就怕一言不和就拒稿的，死都不知道自己怎么死的。 下次再接再厉吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722169, createdTime=Sun Aug 17 22:53:25 CST 2025, time=2025-08-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向：肝脏疾病;肠道菌群 经验分享：中午投稿，晚上状态成Awaiting Reviewer Selection，请问大神这是啥意思？是已经过了编辑那关，准备送外审？还是还在编辑部？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1181, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了，IBD的基础研究综述，大家有类似的经历吗？是不是找不到审稿人，还是要被婉拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2248615, encodeId=2e67224861598, content=想问一下投稿第一天就变成Uerder Review，是编辑内部审，还是送外审了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e645376562, createdName=ms8000002092849593, createdTime=Sat Jan 18 17:02:29 CST 2025, time=2025-01-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样？？？一直是awaiting rewiewer comments？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1775, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586304, encodeId=275458630450, content=审稿速度:1.0 经验分享：刚投一篇meta分析，3小时拒稿，建议转投他们旗下的一个only online的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5259302daef50326f389537442a87163/990afa84b9e72947320d7dfe819c08d5.jpg, createdBy=48d45231791, createdName=墨墨235, createdTime=Tue Mar 10 00:00:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：诊断;消化;肝病 经验分享：投稿难度还是比较大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向：肝病;药物 经验分享：今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=)]

2022-11-18 ms7000001723413329

偏重的研究方向：肝病;药物
经验分享：今天中午提交的

1177 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务